Exciting Collaboration between ONWARD Medical and CEA
ONWARD Medical N.V., a prominent name in the medical technology field, has recently signed an exclusive licensing agreement with CEA, a leader in advanced research. This partnership is focused on the innovative WIMAGINE Brain-Computer Interface (BCI), which has shown promising potential to restore movement in individuals affected by paralysis.
The Capabilities of WIMAGINE BCI
The WIMAGINE BCI is specifically designed to interface directly with the human brain, allowing individuals with spinal cord injuries (SCI) to control their movements using thought alone. With seven years of safety data backing its efficacy, this BCI technology provides a solid foundation for ONWARD's ongoing research and development initiatives.
Innovative Solutions for Restoring Movement
At the heart of this endeavor lies the ONWARD ARC-BCI System, which integrates the WIMAGINE BCI with ONWARD's investigational ARC-IM Therapy. This combination is positioned to not only improve functionality for individuals recovering from SCI but also aims to provide unprecedented control over movement. CEO Dave Marver emphasized the significance of this partnership, stating, "Securing exclusive rights to the WIMAGINE BCI gives us an opportunity to be first to market with a BCI-enabled system to restore thought-driven movement after paralysis."
Successful Trials and Future Directions
Since the inception of testing these systems, notable advancements have been recorded. Initially, researchers reported significant success in allowing individuals augmented control over their movements when paired with ARC-IM Therapy. These initial findings have led to further trials, with multiple participants successfully utilizing the BCI technology to regain movement of their limbs.
The Path Ahead for ONWARD and Clinatec
ONWARD Medical is collaborating closely with teams from CEA and Clinatec to further refine this technology. With generous support from esteemed organizations like the Christopher & Dana Reeve Foundation and the European Innovation Council, these trials aim to explore the efficacy of BCI in not only restoring mobility but also improving the overall quality of life for those affected by SCI.
Commitment to the SCI Community
ONWARD’s unwavering dedication to innovation and partnerships aligns with their mission to develop therapies that can significantly enhance the lives of individuals with spinal cord injuries. Their commitment is not only to technological advancement but to guiding these innovations into clinical application to effect real change.
About ONWARD Medical
Based in Eindhoven, ONWARD Medical has established itself as a trailblazer in the medical technology industry. They specialize in innovative spinal cord stimulation therapies aiming to restore movement and independence. Their flagship product, the ARC Therapy™, has received several Breakthrough Device Designations from the FDA, underlining its revolutionary approach to SCI rehabilitation.
A Global Approach with International Facilities
ONWARD Medical operates internationally, with a Science and Engineering Center in Lausanne, Switzerland, and an office in Boston, Massachusetts. Their collaborative efforts and research initiatives are paving the way for groundbreaking therapies that redefine rehabilitation for spinal cord injury patients.
Frequently Asked Questions
What is the primary goal of the ONWARD and CEA partnership?
The primary goal is to develop and commercialize the WIMAGINE BCI technology, enabling thought-driven movement restoration for people with paralysis.
How does the WIMAGINE BCI work?
The WIMAGINE BCI records brain activity and decodes motor intentions through advanced algorithms, allowing individuals to control movements with their thoughts.
What outcomes has ONWARD Medical achieved so far with its therapies?
ONWARD Medical has achieved successful outcomes in clinical trials where participants regained movement control after spinal cord injuries, significantly improving their quality of life.
What other technologies does ONWARD Medical offer?
In addition to the WIMAGINE BCI, ONWARD offers therapies such as ARC-IM Therapy, which combines external devices with implanted technologies to restore movement.
Where is ONWARD Medical headquartered?
ONWARD Medical is headquartered in Eindhoven, the Netherlands, with additional facilities in Switzerland and the US.
